Sign In
Buy FAMDF
$0.0090
-0.0004 (-4.66%)
At Close: Jun 03, 2026
Futura Medical says Eroxon will be available in US stores and online from October
02:41am, Monday, 02'nd Sep 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) provided keen investors with further details about the US launch plans for its fast-acting gel for erectile dysfunction from blue-chip partner Haleon PLC. The
Futura Medical: Haleon ready launch Eroxon in the US before the year-end
03:01am, Thursday, 01'st Aug 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has received a boost from its blue-chip partner Haleon PLC (LSE:HLN, NYSE:HLN) on the timing of the US roll-out of Eroxon, Futura's fast-acting gel for erectile
Futura: Plenty of catalysts over the next few months, says broker
06:28am, Thursday, 20'th Jun 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s upbeat commentary ahead of its annual meeting garnered a muted response. But broker Liberum believes the company's potential is being significantly underrated
Futura Medical confirms the launch of Eroxon in 10 key markets
03:03am, Thursday, 20'th Jun 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF), the consumer healthcare company behind the fast-acting erectile dysfunction gel Eroxon, has successfully launched its sexual health product in ten countries, i
Futura Medical shares worth 125p, says US investment bank
03:29am, Friday, 19'th Apr 2024
Stifel is projecting peak worldwide sales of $364 million by 2029 for Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s Eroxon, an innovative gel-based treatment for erectile dysfunction (ED). According to t
Futura Medical offers significant and underappreciated opportunity, says Stifel
10:15am, Wednesday, 10'th Apr 2024
Futura Medical PLC's (AIM:FUM, OTC:FAMDF) clinically proven, topical gel treatment for erectile dysfunction, Eroxon, offers a "significant and still underappreciated opportunity", said Stifel as it i
Futura Medical hails landmark year of progress, US preparations going well
02:54am, Wednesday, 10'th Apr 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) hailed a landmark set of annual results after the successful launch of its Eroxon over-the-counter erectile dysfunction (ED) treatment in the Europe and US, wit
Futura Medical ED treatment will be available on prescription from March 1
02:36am, Wednesday, 14'th Feb 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) said Eroxon, its fast-acting erectile dysfunction gel, will be available on prescription in England and Wales from March 1. Eroxon, known for its clinically p
Futura Medical shares jump 36% after trading update; bank says much further
03:46am, Tuesday, 06'th Feb 2024
Shares in Futura Medical PLC (AIM:FUM, OTC:FAMDF) were up 36% in the first hour of trade following its 2023 trading statement, which covered its commercial progress and breakthrough in the US market.
Futura Medical hails breakthrough year following Eroxon's global roll-out and FDA approval
02:48am, Tuesday, 06'th Feb 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) said 2023 was a pivotal year in its commercial journey, marking the successful launch of Eroxon, an over-the-coutner treatment for erectile dysfunction, and th
Futura Medical: Bank sees assesses the importance of contract extension
04:24am, Monday, 15'th Jan 2024
Liberum, the boutique investment bank, has reiterated its 'buy' recommendation and 131p a share price target for Futura Medical PLC (AIM:FUM, OTC:FAMDF) after it announced that it had extended its li
Futura Medical extends deal with European distributor
02:28am, Monday, 15'th Jan 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a specialist in sexual health products, has extended its exclusive licensing agreement with distributor Cooper Consumer Health. Effective until January 2029,
Futura Medical expands Latin American partnership to include a further 14 countries
02:29am, Tuesday, 07'th Nov 2023
In a strategic move to bolster its presence in the Latin American market, Futura Medical PLC (AIM:FUM, OTC:FAMDF) has broadened its licensing agreement with M8 Pharmaceuticals Inc. The expanded contra
Futura Medical wins new product award from Boots
12:15pm, Thursday, 02'nd Nov 2023
Futura Medical's Eroxon erectile dysfunction treatment won the "New Product of the Year, Healthcare" category at the Boots Supplier Awards 2023 following its UK launch earlier this year. James Bard
Futura Medical receives OTC sign-off in Mexico for ED gel
02:42am, Wednesday, 25'th Oct 2023
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in innovative sexual health products, has announced OTC Marketing Authorisation for its topical gel Eroxon from the Mexi
